[CAS NO. 124-76-5] Isoborneol
PRODUCTS SPECIFICATIONS [124-76-5]
DESCRIPTION [124-76-5]
Overview
| MDL | MFCD00074821 |
|---|---|
| Molecular Weight | 154.25 |
| Molecular Formula | C10H18O |
| SMILES | C[C@@]([C@@H]1O)(CC[C@@H]2C1)C2(C)C |
Summary
IC50 & Target
|
HSV-1 |
In Vitro
Isoborneol ((±)-Isoborneol) protects against 6-OHDA-induced increases in caspase-3 activity and cytochrome C translocation into the cytosol from mitochondria. Isoborneol prevents 6-OHDA from decreasing the Bax/Bcl-2 ratio [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : 100 mg/mL ( 648.30 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 6.4830 mL | 32.4149 mL | 64.8298 mL |
| 5 mM | 1.2966 mL | 6.4830 mL | 12.9660 mL |
| 10 mM | 0.6483 mL | 3.2415 mL | 6.4830 mL |
References
- [1] Tian LL, Zhou Z, Zhang Q, et al. Protective effect of (+/-) isoborneol against 6-OHDA-induced apoptosis in SH-SY5Y cells. Cell Physiol Biochem. 2007;20(6):1019‐1032.
- [2] Armaka M, Papanikolaou E, Sivropoulou A, Arsenakis M. Antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1. Antiviral Res. 1999;43(2):79‐92.
Synonyms